Friends Research Institute, Inc.
Clinical trials sponsored by Friends Research Institute, Inc., explained in plain language.
-
App aims to curb meth use and HIV risk in gay men
Disease control CompletedThis study tested a mobile app version of an existing program called "Getting Off" to help gay and bisexual men reduce their methamphetamine use and risky sexual behaviors. 226 men who use methamphetamine participated. The app includes games, lessons, and resources to support beh…
Phase: NA • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Home delivery of addiction meds may keep former prisoners clean
Disease control CompletedThis study looked at 240 prisoners with opioid addiction to see if getting a long-acting naltrexone shot at home after release helps them stay on treatment better than going to a clinic. Participants got one shot in prison and six monthly shots either at a clinic or at home. The …
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated May 18, 2026 12:13 UTC
-
New program aims to close racial gaps in opioid treatment access
Knowledge-focused CompletedThis study looks at a program called NavSTAR that helps people with opioid use disorder start treatment after leaving the hospital. The program is designed to reduce differences in treatment access that affect racial minority groups the most. Researchers will first test the progr…
Phase: NA • Sponsor: Friends Research Institute, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 05:39 UTC
-
App aims to support recovery for justice-involved individuals
Knowledge-focused CompletedThis study tested whether a mobile app could help people on probation or parole who are receiving treatment for substance use disorders. 31 adults used the app alongside their usual care. Researchers measured how easy the app was to use and how satisfied participants were with it…
Phase: NA • Sponsor: Friends Research Institute, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 12:05 UTC